APTV vs EDIT
Aptiv PLC (APTV) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the APTV and EDIT stock pages for the full models.
Not investment advice.